 |
Top 13 Psoriasis treatment startups
Feb 23, 2025 | By Jason Kwon | 24 |
These startups develop new technologies for diagnostics and treatment of psoriasis, such as immunotherapy, light therapy, gene therapy, new drugs like Janus kinase (JAK) inhibitors, topical nanoparticles delivery, etc.
1
Country: USA | Funding: $637M
Nimbus Therapeutics is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
Nimbus Therapeutics is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
2
Country: USA | Funding: $397M
Evelo is pioneering therapies that modulate systemic immune response by acting on the gut-body network - monoclonal microbials. They have the potential to treat many diseases, including inflammatory disease, cancer, autoimmune disease, metabolic, neurobehavior and neuroinflammatory diseases.
Evelo is pioneering therapies that modulate systemic immune response by acting on the gut-body network - monoclonal microbials. They have the potential to treat many diseases, including inflammatory disease, cancer, autoimmune disease, metabolic, neurobehavior and neuroinflammatory diseases.
3
Country: USA | Funding: $259.9M
DermTech is the global leader in molecular dermatology, bringing precision medicine to the diagnosis and treatment of skin disease. We market and develop products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments.
DermTech is the global leader in molecular dermatology, bringing precision medicine to the diagnosis and treatment of skin disease. We market and develop products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments.
4
Country: USA | Funding: $183M
Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class that advances programs in multiple sclerosis and psoriasis
Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class that advances programs in multiple sclerosis and psoriasis
5
Country: UK | Funding: $130M
MiroBio develops novel, best-in-class therapeutics that bring significant benefits to patients suffering from a range of auto-immune diseases. MiroBio's medicines will activate natural mechanisms to regain control of over-active immune responses triggering these diseases.
MiroBio develops novel, best-in-class therapeutics that bring significant benefits to patients suffering from a range of auto-immune diseases. MiroBio's medicines will activate natural mechanisms to regain control of over-active immune responses triggering these diseases.
6
Country: USA | Funding: $70M
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
7
Country: USA | Funding: $67.4M
Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .
Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .
8
Country: Australia | Funding: $62.4M
Botanix Pharmaceuticals intends to improve the lives of patients suffering from serious skin diseases including acne, psoriasis and atopic dermatitis using a novel therapeutic and advanced transdermal drug delivery system.
Botanix Pharmaceuticals intends to improve the lives of patients suffering from serious skin diseases including acne, psoriasis and atopic dermatitis using a novel therapeutic and advanced transdermal drug delivery system.
9
Country: Netherlands | Funding: $19M
Escalier Biosciences develops topical and oral therapeutics for treatment of psoriasis.
Escalier Biosciences develops topical and oral therapeutics for treatment of psoriasis.
10
Country: USA | Funding: $8.6M
SFA Therapeutics, LLC is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs.
SFA Therapeutics, LLC is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs.
11
Country: USA | Funding: $2M
Luma Therapeutics is a medical device company that develops light therapies for the 40M people in the US with inflammatory skin disease. Our first product is focused on helping people with psoriasis.
Luma Therapeutics is a medical device company that develops light therapies for the 40M people in the US with inflammatory skin disease. Our first product is focused on helping people with psoriasis.
13
Country: USA
Alumis is a precision medicines company that is transforming the lives of patients living with immune-mediated diseases using a precision approach to develop oral therapies.
Alumis is a precision medicines company that is transforming the lives of patients living with immune-mediated diseases using a precision approach to develop oral therapies.
